10-Q
Alpha Star Acquisition Corp (ALSAF)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 10-Q
(Mark
One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Forthe quarterly period ended March 31, 2022
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Forthe transition period from to
Commission
File No. 001-41153
| ALPHA STAR ACQUISITION CORPORATION | |
|---|---|
| (Exact<br><br> name of registrant as specified in its charter) | |
| Cayman Islands | N/A 00-0000000 |
| --- | --- |
| (State or other jurisdiction<br><br> of<br><br><br> incorporation or organization) | (I.R.S. Employer<br><br><br> Identification No.) |
| 80 Broad Street**, 5^th^Floor**<br><br><br> <br>New York, New York 10004 | |
| --- | |
| (Address<br><br> of Principal Executive Offices, including zip code) | |
| (212) 837 - 7977 | |
| --- | |
| (Registrant’s<br><br> telephone number, including area code) | |
| Not Applicable | |
| --- | |
| (Former<br><br> name, former address and former fiscal year, if changed since last report) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Nameof each exchange on which registered |
|---|---|---|
| Units, each consisting of<br><br> one ordinary share, one redeemable warrant, and one right | ALSAU | The Nasdaq Stock Market<br><br> LLC |
| Ordinary Shares, $0.001<br><br> par value | ALSA | The Nasdaq Stock Market<br><br> LLC |
| Redeemable<br><br>warrants entitle the holder to purchase one-half (1/2) of one ordinary share | ALSAW | The<br><br>Nasdaq Stock Market LLC |
| Rights<br><br> entitle the holders to receive one-seventh (1/7) of one Ordinary Share | ALSAR | The<br><br> Nasdaq Stock Market LLC |
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405
of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). Yes ☒ No ☐
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| ☐ | Large accelerated filer | ☐ | Accelerated filer |
|---|---|---|---|
| ☒ | Non-accelerated filer | ☒ | Smaller reporting company |
| ☒ | Emerging growth company |
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☒ No ☐
Indicate the number of shares outstanding of each of
the registrant’s classes of ordinary shares, as of the latest practicable date: As of May 6, 2022, there
were 14,705,000 ordinary shares, par value of $0.001, issued and
outstanding (assuming all of the units issued in our initial public offering completed on December 15, 2021 were split on such date).
ALPHA
ACQUISITION CORPORATION
FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2022
TABLE
OF CONTENTS
| Page | ||
|---|---|---|
| Part I. Financial Information | ||
| Item<br><br> 1. | Financial<br><br> Statements | 1 |
| Balance Sheets (Unaudited) | 1 | |
| Statements of Operations (Unaudited) | 2 | |
| Statements of Changes in Stockholders’ Equity (Deficit) (Unaudited) | 3 | |
| Statements of Cash Flows (Unaudited) | 4 | |
| Notes to Unaudited Financial Statements | 5 | |
| Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 15 |
| Item 3. | Quantitative and Qualitative Disclosures Regarding Market Risk | 18 |
| Item 4. | Controls and Procedures | 18 |
| Part II. Other Information | 19 | |
| Item 1. | Legal Proceedings | 19 |
| Item 1A. | Risk Factors | 19 |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 19 |
| Item 3. | Defaults Upon Senior Securities | 19 |
| Item 4. | Mine Safety Disclosures | 19 |
| Item 5. | Other Information | 19 |
| Item 6. | Exhibits | 20 |
| Part III. Signatures | 21 |
i
ALPHA
STAR ACQUISITION CORPORATION
BALANCE
SHEETS
(Unaudited)
| December 31, | |||||
|---|---|---|---|---|---|
| 2021 | |||||
| ASSETS | |||||
| Current assets: | |||||
| Cash in escrow | 188,773 | $ | 387,858 | ||
| Prepaid expense | 105,206 | 142,192 | |||
| Marketable securities held in trust account | 115,010,130 | 115,000,744 | |||
| Total current assets | 115,304,109 | 115,530,794 | |||
| TOTAL ASSETS | 115,304,109 | $ | 115,530,794 | ||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||
| Current liabilities: | |||||
| Accrued expenses | 5,793 | $ | 52,999 | ||
| Deferred underwriting commissions | 2,875,000 | 2,875,000 | |||
| Total current liabilities | 2,880,793 | 2,927,999 | |||
| TOTAL LIABILITIES | 2,880,793 | 2,927,999 | |||
| COMMITMENTS AND CONTINCENCIES | |||||
| Ordinary shares subject to possible redemption, 11,500,000 shares at redemption value of 10.00 per share | 115,000,000 | 115,000,000 | |||
| Stockholders’ Deficit: | |||||
| Ordinary shares, 0.001 par value; 50,000,000 shares authorized; 3,205,000 and 3,205,000 shares issued and outstanding at March 31, 2022 and December 31, 2021 respectively, excluding 11,500,000 shares subject to possible redemption | 3,205 | 3,205 | |||
| Additional paid-in capital | - | - | |||
| Accumulated deficit | (2,579,889 | ) | (2,400,410 | ) | |
| Total Stockholders’ Equity (Deficit) | (2,576,684 | ) | (2,397,205 | ) | |
| TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | 115,304,109 | $ | 115,530,794 |
All values are in US Dollars.
The
accompanying notes are an integral part of the unaudited financial statements.
1
AlphaStar Acquisition CorporationStatements of Operations(Unaudited)
| For the<br> Three Months Ended<br> March 31,<br> 2022 | For the<br> Period from<br> March 11, 2021<br> (inception) to<br> March 31,<br> 2021 | ||||
|---|---|---|---|---|---|
| Formation and operational costs | $ | 188,865 | $ | – | |
| Loss from operation costs | 188,865 | – | |||
| Other income: | |||||
| Interest income | 9,386 | – | |||
| Total other income | 9,386 | – | |||
| Loss before income taxes | (179,479 | ) | – | ||
| Net Loss | $ | (179,479 | ) | $ | – |
| Basic and diluted weighted average shares outstanding – ordinary shares subject to redemption | 11,500,000 | $ | – | ||
| Basic and diluted net loss per share | $ | (0.01 | ) | $ | - |
| Basic and diluted<br> weighted average shares outstanding - non redeemable ordinary shares^(1)^ | 3,205,000 | 2,875,000 | |||
| Basic and diluted net loss per share | $ | (0.01 | ) | $ | 0.00 |
| (1) | Retrospectively restated for the 1 founder share issuance and cancellation; 2,875,000<br>shares to the Company by the Sponsor for $25,000 in April 2021, including of up to 375,000 shares subject to forfeiture, as over-allotment<br>option was fully exercised by the underwriters. | ||||
| --- | --- |
The
accompanying notes are an integral part of the unaudited financial statements.
2
ALPHA
STAR ACQUISITION CORPORATION
STATEMENTS
OF CHANGES IN STOCKHOLDERS’ DEFICIT
(Unaudited)
Period ended from March 11, 2021 (Inception) to March 31, 2021
| Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary shares | Paid-In | Accumulated | Stockholders’ | ||||||||
| Shares | Amount | Capital | Deficit | Equity | |||||||
| Balance at March 11, 2021 (inception) | - | $ | - | $ | - | $ | - | $ | - | ||
| Issuance of founder share to Sponsor^(1)^ | 1 | - | - | - | - | ||||||
| Cancellation of founder Share to Sponsor^(1)^ | (1 | ) | - | - | - | - | |||||
| Issuance of ordinary shares to Sponsor^(1)^ | 2,875,000 | 2,875 | 22,125 | - | 25,000 | ||||||
| Balance at March 31, 2021 | **** | 2,875,000 | **** | $ | 2,875 | $ | 22,125 | $ | - | $ | 25,000 |
| (1) | Retrospectively<br> restated for the 1 founder share issuance and cancellation; 2,875,000 shares to the Company by the Sponsor for $25,000 in April<br> 2021, including of up to 375,000 shares subject to forfeiture, as over-allotment option was fully exercised by the<br> underwriters. | ||||||||||
| --- | --- |
Three months ended March 31, 2022
| Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary shares | Paid-In | Accumulated | Stockholders’ | |||||||||
| Shares | Amount | Capital | Deficit | Equity | ||||||||
| Balance at January 1, 2022 | 3,205,000 | $ | 3,205 | $ | - | $ | (2,400,410 | ) | $ | (2,397,205 | ) | |
| Net loss | - | - | - | (179,479 | ) | (179,479 | ) | |||||
| Balance at March 31, 2022 | **** | 3,205,000 | $ | 3,205 | $ | - | $ | (2,579,889 | ) | $ | (2,576,684 | ) |
The
accompanying notes are an integral part of the unaudited financial statements.
3
ALPHA
STAR ACQUISITION CORPORATION
STATEMENTS
OF CASH FLOWS
(Unaudited)
| For the<br><br><br>three months ended<br><br><br>March 31,<br><br><br>2022 | For the<br><br><br>period<br><br><br>from<br><br><br>March 11, 2021<br><br><br>(inception) to<br><br><br>March 31,<br><br><br>2021 | ||||
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | $ | (179,479 | ) | $ | - |
| Adjustments to reconcile net income (loss) to net cash Used in operating<br><br> activities: | |||||
| Interest earned in trust account | (9,386 | ) | - | ||
| Amortization of prepaid expense | 36,986 | - | |||
| Accrued expenses | (47,206 | ) | - | ||
| Net cash used in operating activities | **** | (199,085 | ) | **** | - |
| Cash flows from financing activities: | |||||
| Proceeds from issuance of ordinary shares<br> to the Sponsor | - | 25,000 | |||
| Proceeds of promissory note from Sponsor | - | 300,000 | |||
| Net cash provided by financing activities | **** | - | **** | **** | 325,000 |
| Net increase in cash and cash equivalents | (199,085 | ) | 325,000 | ||
| Cash and cash equivalents at beginning of period | 387,858 | - | |||
| Cash and cash equivalents at end of period | $ | 188,773 | **** | $ | 325,000 |
| Supplemental disclosure of cash flow information | |||||
| Deferred offering costs included in accrued offering costs | $ | - | $ | 40,000 |
The accompanying notes are an integral part of the unaudited financial statements.
4
ALPHA
STAR ACQUISITION CORPORATION
UNAUDITED
NOTES TO THE FINANCIAL STATEMENTS
Note1 – Description of Organization and Business Operations
Organizationand General
Alpha
Star Acquisition Corporation (the “Company”) is a blank check company incorporated in the Cayman Islands on March 11,
- The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (“Business Combination”). The Company has selected December 31
as its fiscal year-end.
Although
the Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination, the Company
intends to focus on businesses that have a connection to the Asian market. The Company is an early stage and emerging growth company
and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
The
Company’s sponsor is A-Star Management Corporation, a British Virgin Islands incorporated company (the “Sponsor”).
The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company
will generate non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering (the “IPO”).
The Company has 9 months from the closing of the IPO (or up to 21 months from the closing of our initial public offering if we extend the period of time to consummate a business combination) to consummate a Business Combination (the “Combination Period”). If the Company fails to consummate a Business Combination within the Combination Period, it will trigger its automatic winding up, liquidation and subsequent dissolution pursuant to the terms of the Company’s amended and restated memorandum and articles of association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under the Companies Law. Accordingly, no vote would be required from the Company’s stockholders to commence such a voluntary winding up, liquidation and subsequent dissolution.
The
Company’s IPO was declared effective on December 13, 2021. On December 15, 2021, the Company consummated the IPO of 11,500,000 units
which includes an additional 1,500,000 units as a result of the underwriters’ fully exercise of the over-allotment, at
$10.00 per Unit, generating gross proceeds of $115,000,000, which is described in Note 3.
Concurrently
with the closing of the IPO, the Company consummated the sale of 330,000 units (the “Private Placement”) at a price
of $10.00 per Private Unit in a private placement to A-Star Management Corporation, generating gross proceeds of $3,300,000, which
is described in Note 4.
TheTrust Account
As
of December 15, 2021, a total of $115,682,250 of the net proceeds from the IPO and the Private Placement transaction completed with the Sponsor was deposited in a trust account established for the benefit of the Company’s public stockholders with Wilmington Trust, National Association acting as trustee. The amount exceeding $115,000,000, $682,254, had been transfer to the Company’s escrow cash account as its working capital. At March 31, 2022, the Company had working capital of $288,185, which excludes $115,010,130 of marketable securities held in the trust account and the liability for deferred underwriting commissions of $2,875,000.
The
funds held in the Trust Account are invested only in United States government treasury bills, bonds or notes having a maturity of
180 days or less, or in money market funds meeting the applicable conditions under Rule 2a-7 promulgated under the Investment Company
Act of 1940 and that invest solely in United States government treasuries. Except with respect to interest earned on the funds held in
the Trust Account that may be released to the Company to pay its income or other tax obligations, the proceeds will not be released from
the Trust Account until the earlier of the completion of a Business Combination or the Company’s liquidation.
5
Liquidityand Going Concern
As
of March 31, 2022, the Company had cash $188,773 in its escrow account and working capital of $288,185, which excludes $115,010,130 of marketable securities held in the trust account and the liability for deferred underwriting commissions of $2,875,000.
The
Company’s liquidity needs to date have been satisfied through a payment of $25,000 from the Sponsor to cover certain expenses
on behalf of the Company in exchange for the issuance of the Founder Shares and the proceeds from the consummation of the Private Placement
not held in the Trust Account to provide working capital needed to identify and seek to consummate a Business Combination.
In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain
of the Company’s officers and directors may, but are not obligated to, provide the Company related party loans up to $1,500,000. As of March 31,
2022, the Company had no borrowings under the related party loans.
If
the Company’s estimate of the costs of identifying a target business, undertaking due diligence and negotiating a Business Combination
are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate our business prior to
our initial Business Combination. Moreover, the Company may need to obtain additional financing either to complete its Business Combination
or because the Company has become obligated to redeem a significant number of its Public Shares upon completion of its Business Combination,
in which case the Company may issue additional securities or incur debt in connection with such Business Combination. In addition, we
have until September 15, 2023 (the “Liquidation Date”) to consummate a business combination.
In
connection with the Company’s assessment of going concern considerations in accordance with Accounting Standards Codification (“ASC”)
205-40, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined
that if the Company is unable to complete a Business Combination by the Liquidation Date, then the Company may cease all operations except
for the purpose of liquidating. The uncertainty surrounding the date for mandatory liquidation and subsequent dissolution raise substantial
doubt about the Company’s ability to continue as a going concern. Management expects to close the Business Combination prior to
the Liquidation Date. If the Company is unable to close the Business Combination or raise additional capital, it may be required to take
additional measures to conserve liquidity, which could include, but not necessarily include or be limited to, curtailing operations,
suspending the pursuit of a potential transaction and reducing overhead expenses. The Company cannot provide any assurance that new financing
will be available to it on commercially acceptable terms or if at all. These conditions raise substantial doubt about the Company’s
ability to continue as a going concern through the Liquidation Date if a Business Combination is not consummated. These financial statements
do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be
necessary should the Company be unable to continue as a going concern.
Management
believes that, on March 31, 2022, the company has insufficient working capital to cover its short term operating needs. The Company has
no revenue before the Business Combination. Its business plan is dependent on the completion of a financing transaction and the Company’s
cash and working capital as March 31, 2022 are not sufficient to complete its planned activities for the upcoming year. These factors
raise substantial doubt about the Company’s ability to continue as a going concern one year from the date the financial statement
is issued.
Note2 – Summary of Significant Accounting Policies
Basisof Presentation
The
accompanying financial statement of the Company are presented in U.S. dollars in conformity with accounting principles generally accepted
in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission
(“SEC”).
These unaudited financial statements should be read in conjunction
with the Company’s audited consolidated financial statements and the notes thereto included in the Annual Report for the year ended
December 31, 2021, which are included in Form 10-K filed on March 30, 2022.
6
EmergingGrowth Company
The
Company is an emerging growth company as defined by Section 2(a) of the JOBS Act and it may take advantage of certain exemptions from
various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but no
limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced
disclosures obligations regarding executive compensation in its periodic reports and proxy statements, and exceptions from the requirements
of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payment not previously
approved.
Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out
of such extended transition period which means that when a standard is issued or revised, and it has different application dates for
public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s financial statement with another public company which
is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult
or impossible because of the potential differences in accounting standards used.
Useof Estimates
The preparation of financial statement in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. The initial valuation of the public warrants and private warrants (as defined in Note 7) and ordinary shares subject to redemption required management to exercise significant judgement in its estimates. Accordingly, the actual results could differ significantly from those estimates.
Cashand Cash Equivalents
The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
The Company had $188,773 and $387,858 cash held in escrow and did not have any cash equivalents as of March 31, 2022 and December
31, 2021, respectively.
Concentrationof Credit Risk
Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution
which, at times may exceed the Federal depository insurance coverage of $250,000. As of March 31, 2022 and December 31, 2021, the Company
had not experienced losses on this account respectively.
MarketableSecurities Held in Trust Account
The
Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying condensed statements of operations. The estimated fair values of investments held in Trust Account are determined using available market information. The Company had $115,010,130 and $115,000,744 of marketable securities held in the trust account as of March 31, 2022 and December 31, 2021, respectively.
7
OfferingCosts Associated with the Initial Public Offering
Offering
costs consist of underwriting, legal, accounting, registration and other expenses incurred through the balance sheet date that are directly
related to the IPO. As of March 31, 2022, offering costs amounted to $5,669,696 consisting of $2,300,000 of underwriting fees,
$2,875,000 of deferred underwriting fees, and $494,696 of other offering costs. The Company complies with the requirements
of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin Topic 5A – “Expenses of Offering”. The Company allocates offering
costs between public shares, public rights and public warrants based on the estimated fair values of public shares, public warrants,
and public rights at the date of issuance.
OrdinaryShares Subject to Possible Redemption
The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption is
classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares
that feature redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company’s control) is classified as temporary equity. At all other times, ordinary shares are classified
as stockholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside
of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible
redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s
balance sheet.
All
of the 11,500,000 ordinary shares sold as part of the Units in the IPO contain a redemption feature which allows for the redemption of such
Public Shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with
the Business Combination and in connection with certain amendments to the Company’s Certificate of Incorporation. Accordingly,
all of the 11,500,000 shares
of ordinary shares are presented as temporary equity.
The
Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable ordinary shares
to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable ordinary
shares are affected by charges against additional paid-in capital and accumulated deficit if additional paid in capital equals to
zero.
FairValue of Financial Instruments
The
fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet,
primarily due to the short-term nature.
NetIncome (Loss) per Share
The
Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” In order to determine
the net income (loss) attributable to both the redeemable shares and non-redeemable shares, the Company first considered the undistributed
income (loss) allocable to both the redeemable shares and non-redeemable shares and the undistributed income (loss) is calculated using
the total net loss less any dividends paid. The Company then allocated the undistributed income (loss) ratably based on the weighted
average number of shares outstanding between the redeemable and non-redeemable shares. Any remeasurement of the accretion to redemption
value of the ordinary shares subject to possible redemption was considered to be dividends paid to the public stockholders.
The
calculation of diluted income (loss) per ordinary shares does not consider the effect of the warrants issued in connection with the (i) Initial
Public Offering, and (ii) the private placement since the exercise of the warrants is contingent upon the occurrence of future events.
The warrants are exercisable to purchase 5,915,000 shares of ordinary shares in the aggregate. As of March 31, 2022, the
Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into ordinary shares
and then share in the earnings of the Company. As a result, diluted net income (loss) per ordinary shares is the same as basic net income
(loss) per ordinary share for the periods presented.
8
The
net income (loss) per share presented in the statement of operations is based on the following:
| Schedule of<br><br> income loss per share | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| For the<br> Three months ended<br><br><br> March 31,<br> 2022 | For the<br><br><br>Period from<br><br><br>March 11, 2021 (Inception) to<br><br><br>March 31,<br><br><br>2021 | |||||||||
| Net loss | $ | (179,479 | ) | $ | - | |||||
| Schedule of basic and diluted net income (loss) per share | ||||||||||
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| For the<br> Three months ended<br><br><br>March 31,<br> 2022 | For the<br><br><br>period from<br> March 11,<br><br> 2021<br> (inception) to<br> March 31,<br> 2022 | |||||||||
| Non-redeemable<br><br><br>shares | Redeemable<br><br><br>shares | Non-redeemable<br><br><br>shares | Redeemable<br><br><br>shares | |||||||
| Basic and Diluted net income (loss) per share: | ||||||||||
| Numerators: | ||||||||||
| Allocation of net loss | $ | (39,118 | ) | $ | (140,361 | ) | $ | - | $ | - |
| Allocation of net income (loss) | $ | (39,118 | ) | $ | (140,361 | ) | $ | - | $ | - |
| Denominators: | ||||||||||
| Weighted-average shares outstanding | 3,205,000 | 11,500,000 | 2,875,000 | - | ||||||
| Basic and diluted net income (loss) per share | $ | (0.01 | ) | $ | (0.01 | ) | $ | 0.00 | $ | - |
IncomeTaxes
The
Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax
assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation
allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC
740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes
a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected
to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination
by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim
period, disclosure and transition. The Company has identified the Cayman Islands as its only “major” tax jurisdiction, as
defined. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring
recognition in the Company’s financial statement. Since the Company was incorporated on March 11, 2021, the evaluation was performed
for the period ended March 31, 2022 which will be the only period subject to examination. The Company believes that its income tax positions
and deductions would be sustained on audit and does not anticipate any adjustments that would result in material changes to its financial
position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component
of income tax expense.
The provision for income taxes was deemed to be immaterial for three months ended March 31, 2022 and for the period end from March 11, 2021 to March 31, 2021.
9
Warrants
The
Company evaluates the Public and Private Warrants as either equity-classified or liability-classified instruments based on
an assessment of the warrants’ specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”)
Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815,
Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments
pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for
equity classification under ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares, among other
conditions for equity classification. Pursuant to such evaluation, both Public and Private Warrants are classified in stockholders’
equity.
RecentlyIssued Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2020-06, Debt — Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”) to simplify accounting for certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective on January 1, 2022 and should be applied on a full or modified retrospective basis, with early adoption permitted beginning on January 1, 2021. As of March 31, 2022, management does not believe that any recently effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Note3 – Initial Public Offering
On
December 15, 2021, the Company consummated the initial public offering and sale of 11,500,000 units (including the issuance
of 1,500,000 units as a result of the underwriters’ fully exercise of the over-allotment) at a price of $10.00 per
Unit, generating gross proceeds of $115,000,000. Each Unit consists of one ordinary share, one redeemable warrant (each a “Warrant”,
and, collectively, the “Warrants”), and one right to receive one-seventh (1/7) of an ordinary share upon the consummation
of a Business Combination. Each two redeemable warrants entitle the holder thereof to purchase one ordinary share, and each seven rights
entitle the holder thereof to receive one ordinary share at the closing of a Business Combination. No fractional shares issued upon separation
of the Units, and only whole Warrants will trade.
Note4 – Private Placement
Concurrently
with the consummation of the IPO, A-Star Management Corporation, the Sponsor, purchased an aggregate of 330,000 units at a
price of $10.00 per Private Unit for an aggregate purchase price of $3,300,000 in a private placement. The Private Units are
identical to the public Units except with respect to certain registration rights and transfer restrictions. The proceeds from the Private
Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete a Business Combination
within the Combination Period, the proceeds from the sale of the Private Units will be used to fund the redemption of the Public Shares
(subject to the requirements of applicable law), and the Private Units and all underlying securities will expire worthless.
10
Note5 – Related Party Transactions
FounderShares
On
March 11, 2021, the Company issued one ordinary share to the Sponsor for no consideration. On April 6, 2021, the Company cancelled
the one share for no consideration and the Sponsor purchased 2,875,000 ordinary shares for an aggregate price of $25,000.
The 2,875,000 founder
shares (for purposes hereof referred to as the “Founder Shares”) include an aggregate of up to 375,000 shares subject
to forfeiture by the Sponsor to the extent that the underwriters’ over-allotment is not exercised in full or in part, so that the
Sponsor will collectively own 20% of the Company’s issued and outstanding shares after the Proposed Offering. On December 15, 2021,
the underwriters exercised the over-allotment option in full, so there are no Founder Shares subject to forfeiture as of March 31, 2022.
The
Sponsor and each Insider agrees that it, he or she shall not (a) Transfer 50% of their Founder Shares until the earlier of (A) six
months after the consummation of the Company’s initial Business Combination or (B) the date on which the closing price of
the Ordinary Shares equals or exceeds $12.50 per share (as adjusted for share splits, share capitalizations, rights issuances, subdivisions,
reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s
initial Business Combination or (b) Transfer the remaining 50% of their Founder Shares until six months after the date of the consummation
of the Company’s initial Business Combination, or earlier in either case, if subsequent to the Company’s initial Business
Combination the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in
all of the Company’s stockholders having the right to exchange their Ordinary Shares for cash, securities or other property (the
“Founder Shares Lock-up Period”).
AdministrativeServices Agreement
The
Company entered into an administrative services agreement, commencing on December 13, 2021, through the earlier of the Company’s
consummation of a Business Combination or its liquidation, to pay to the Sponsor a total of $10,000 per month for office space,
secretarial and administrative services provided to members of the Company’s management team. From January
1, 2022 through March 31, 2022 and from March 11, 2021 (inception) through March 31, 2021, the Company incurred $30,000
and nil 0 in fees for these services respectively.
SponsorPromissory Note — Related Party
On
March 26, 2021, the Company issued an unsecured promissory note to the Sponsor, pursuant to which the Company may borrow up to
an aggregate principal amount of $300,000 (the
“Promissory Note”). The Promissory Note is non-interest bearing and payable on the earlier of (i) December 31,
2021 or (ii) the consummation of the Proposed Offering. The loan repaid as $300,000 allotted
to the payment of offering expense. Sponsor promissory note balance were nil 0
and nil 0 as of March 31, 2022 and December 31, 2021 respectively.
In addition, in order to finance transaction costs in connection with
an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and directors may, but
are not obligated to, loan us funds as may be required. If we complete an initial business combination, we would repay such loaned amounts.
In the event that the initial business combination does not close, we may use a portion of the working capital held outside the trust
account to repay such loaned amounts but no proceeds from our trust account would be used for such repayment. Up to $1,500,000 of such
loans may be convertible into units at a price of $10.00 per unit (which, for example, would result in the holders being issued 150,000
ordinary shares, 150,000 rights and 150,000 warrants to purchase 75,000 shares if $1,500,000 of notes were so converted) at the option
of the lender. The units would be identical to the placement units issued to the initial holder. The terms of such loans by our officers
and directors, if any, have not been determined and no written agreements exist with respect to such loans. We do not expect to seek loans
from parties other than our sponsor or an affiliate of our sponsor as we do not believe third parties will be willing to loan such funds
and provide a waiver against any and all rights to seek access to funds in our trust account.
Note6 – Commitments and Contingencies
Risksand Uncertainties
Management
continues to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could
have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific
impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments
that might result from the outcome of this uncertainty.
UnderwritersAgreement
The
Company granted the underwriters, a 45-day option to purchase up to 1,500,000 Units (over and above the 10,000,000 units referred to
above) solely to cover over-allotments at $10.00 per Unit. On December 15, 2021, the underwriters exercised the over-allotment option
in full to purchase 1,500,000 Units at a purchase price of $10.00 per Unit.
11
On
December 15, 2021, the Company paid a cash underwriting commission of 2.0% of the gross proceeds of the IPO, or $2,300,000.
The
underwriters are entitled to a deferred underwriting commission of 2.5% of the gross proceeds of the IPO, or $2,875,000, which will
be paid from the funds held in the Trust Account upon completion of the Company’s initial Business Combination subject to the terms
of the underwriting agreement. The Company has the deferred underwriting commissions $2,875,000 and $2,875,000 as current liabilities
as of March 31, 2022 and December 31, 2021, respectively.
RegistrationRights
The
holders of the Founder Shares will be entitled to registration rights pursuant to a registration rights agreement to be signed prior
to or on the effective date of the IPO. The holders of these securities are entitled to make up to three demands, excluding
short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration
rights with respect to registration statements filed subsequent to the consummation of a Business Combination and rights to require the
Company to register for resale such securities pursuant to Rule 415 under the Securities Act. The Company will bear the expenses
incurred in connection with the filing of any such registration statements.
Note7 – Stockholders’ Deficit
OrdinaryShares
The
Company is authorized to issue 50,000,000 ordinary shares, with a par value of $0.001 per share. Holders of the ordinary
shares are entitled to one vote for each ordinary share. At March 31, 2022, there were
3,205,000
ordinary shares issued
and outstanding, excluding 11,500,000 shares subject to possible redemption. The Sponsor has agreed to forfeit 375,000 ordinary
shares to the extent that the over-allotment option is not exercised in full by the underwriters. On December 15, 2021, the underwriters
fully exercised the over-allotment option, as such there are no ordinary shares subject to forfeiture. As of March 31, 2021, the Company’s historical stockholders’ equity was retrospectively restated to the first period, the amount of 2,875,000 shares to the Company by the Sponsor for $2,875 at par value $0.0001, with additional paid-in capital $22,125 in April 2021, includes of up to 375,000 shares subject to forfeiture, as over-allotment option is fully exercised by the underwriters.
PublicWarrants
Pursuant
to the Initial Public Offering, the Company sold 11,500,000 Units at a price of $10.00 per Unit for a total of $115,000,000.
The total amount of ordinary shares subject to possible redemption is 11,500,000. Each Unit consists of one ordinary share, one
right to acquire one-seventh (1/7) of an ordinary share, and one redeemable warrant (“Public Warrant”) to purchase one-half
of one ordinary share at a price of $11.50 per share, subject to adjustment.
Each
warrant entitles the holder to purchase one-half ordinary share at a price of $11.50 per share commencing 30 days after the completion
of its initial business combination and expiring five years from after the completion of an initial business combination. No fractional
warrant will be issued and only whole warrants will trade. The Company may redeem the warrants at a price of $0.01 per warrant upon
30 days’ notice, only in the event that the last sale price of the ordinary shares is at least $18.00 per share for any 20 trading
days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there
is an effective registration statement and current prospectus in effect with respect to the ordinary shares underlying such warrants
during the 30 day redemption period. If a registration statement is not effective within 60 days following the consummation
of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period
when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to
an available exemption from registration under the Securities Act.
In
addition, if (a) the Company issues additional ordinary shares or equity-linked securities for capital raising purposes in connection
with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (with
such issue price or effective issue price to be determined in good faith by our board of directors), (b) the aggregate gross proceeds
from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of our
initial business combination, and (c) the volume weighted average trading price of the ordinary shares during the 20 trading
day period starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price,
the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent)
to be equal to 115% of the Market Value, and the last sales price of the ordinary shares that triggers the Company’s right
to redeem the Warrants will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.
12
Privatewarrants
The
private warrants have terms and provisions that are identical to those of the warrants being sold as part of the units in this offering.
Rights
Except
in cases where the Company is not the surviving Company in a business combination, the holders of the rights will automatically receive 1/7 of
a share of ordinary shares upon consummation of the Company’s initial business combination. In the event the Company will not be
the surviving company upon completion of the initial business combination, each holder of a right will be required to affirmatively convert
his, her or its rights in order to receive the 1/7 of a share underlying each right upon consummation of the business combination. As
of March 31, 2022, no rights had been issued.
Note8 – Fair Value Measurements
The
Company complies with ASC 820, “Fair Value Measurements”, for its financial assets and liabilities that are re-measured and
reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair
value at least annually. ASC 820 determines fair value to be the price that would be received to sell an asset or would be paid to transfer
a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date.
The
following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used
in order to value the assets and liabilities:
Level
1: Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which
transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level
2: Observable inputs other than Level inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or
liabilities and quoted prices for identical assets or liabilities in markets that are not active.
Level
3: Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
At
March 31, 2022 and December 31, 2021, assets held in the trust account were entirely comprised of marketable securities.
The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis at March 31,
2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair
value.
| Schedule of fair value, assets and liabilities measured on recurring basis | ||||||
|---|---|---|---|---|---|---|
| Assets March 31, 2022 | Quoted Prices in<br> Active Markets<br> (Level 1) | Significant Other<br> Observable Inputs<br> (Level 2) | Significant Other<br> Unobservable Inputs<br> (Level 3) | |||
| Marketable Securities held in Trust Account | $ | 115,010,130 | $ | - | $ | - |
| Assets December 31, 2021 | Quoted Prices in<br> Active Markets<br> (Level 1) | Significant Other<br> Observable Inputs<br> (Level 2) | Significant Other<br> Unobservable Inputs<br> (Level 3) | |||
| --- | --- | --- | --- | --- | --- | --- |
| Marketable Securities held in Trust Account | $ | 115,000,744 | $ | - | $ | - |
13
Note9 – Subsequent Events
The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to May 13, 2022 the date
the financial statement was available to be issued. Based upon the review, the Company did not identify any subsequent events that would
have required adjustment or disclosure in the financial statement.
14
ITEM
- MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References
in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Alpha
Star Acquisition Corporation. References to our “management” or our “management team” refer to our officers and
directors, and references to the “Sponsor” refer to A-Star Management Corporation. The following discussion and analysis
of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and
the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.
Special Note RegardingForward-Looking Statements
This
Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E
of the Exchange Act that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially
from those expected and projected. All statements, other than statements of historical fact included in this Form 10-Q including,
without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations”
regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations,
are forward-looking statements. Words such as “anticipate,” “believe,” “continue,” “could,”
“estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,”
“potential,” “predict,” “project,” “should,” “would” and variations
thereof and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate
to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number
of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed
in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially
from those anticipated in the forward-looking statements. The Company’s securities filings can be accessed on the EDGAR
section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any
intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We
are a blank check company incorporated in the Cayman Islands on March 11, 2021 formed for the purpose of effecting a merger, share exchange,
asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate
our Business Combination using cash derived from the proceeds of the Initial Public Offering and the sale of the Private Units, our shares,
debt or a combination of cash, shares and debt.
We
expect to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business
Combination will be successful.
Results of Operations
We
have neither engaged in any operations nor generated any operating revenues to date. Our only activities from inception through March
31, 2022 were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and identifying
a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial
Business Combination. We expect to generate non-operating income in the form of interest income on marketable securities held in the trust account. We expect that we will incur increased expenses as a result of being a public company (for legal, financial
reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with searching for, and completing,
a Business Combination.
For
the three months ended March 31, 2022, we had a net loss of $179,479, which consists of operating costs of $188,865, offset by interest
income on marketable securities held in the Trust Account of $9,386.
For
the period ended from March 11, 2021 (inception date) to March 31, 2021, we had a net loss as nil, the Company had no operating or administrative
activities in this period.
15
Liquidity and CapitalResources
Until
the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of ordinary shares by the Sponsor
and loans from our Sponsor.
On
December 15, 2021, the Company consummated the IPO of 11,500,000 units (including the exercise of the over-allotment option by the underwriters
in the IPO) at $10.00 per unit (the “Public Units”), generating gross proceeds of $115,000,000. Each Unit consists of one
ordinary share, one redeemable warrant to purchase one-half (1/2) ordinary share (each a “Warrant”, and, collectively, the
“Warrants”), and one right to receive one-seventh (1/7) of an ordinary share upon the consummation of a Business Combination.
Simultaneously with the IPO, the Company sold to its Sponsor 330,000 units at $10.00 per unit in a private placement generating total
gross proceeds of $3,300,000. Offering costs amounted to $5,669,696 consisting of $2,300,000 of underwriting fees, $2,875,000 of deferred
underwriting fees, and 494,696 of other offering costs. Except for $25,000 of subscription of ordinary shares, the Company received net
proceeds of $115,682,250 from the IPO and the private placement.
For
the three months ended March 31, 2022, net cash used in operating activities was $199,085. Net loss of $179,479 was consistent with formation
and operating costs $188,865 and offset by interest earned on marketable securities held in trust of $9,386. Net cash provided
by financing activities was nil.
For the period ended from March 11, 2021 (inception date) to March 31, 2021, net cash used in operating activities was nil. Net cash provided by financing activities was $325,000, which the Company received from the Sponsor on the promissory note of $300,000 for funding the preparation of IPO, and the Sponsor’s subscription for the 2,875,000 ordinary shares at $0.001 par value, for a total of $25,000.
At March 31, 2022, we had marketable securities held in the trust account of $115,010,130. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account, excluding deferred underwriting commissions, to complete our Business Combination. We may withdraw interest from the Trust Account to pay taxes, if any. To the extent that our share capital or debt is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
At
March 31, 2022, we had cash of $188,773 held outside of the Trust Account. We intend to use the funds held outside the Trust Account
primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and
from the offices, plants or similar locations of prospective target businesses or their representatives or owners, review corporate documents
and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In
order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an
affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. Such
Working Capital Loans would be evidenced by promissory notes. If we complete a Business Combination, we may repay such notes out of the
proceeds of the Trust Account released to us. In the event that a Business Combination does not close, we may use a portion of the working
capital held outside the Trust Account to repay such notes, but no proceeds from our Trust Account would be used for such repayment.
Up to $1,500,000 of notes may be convertible into units, at a price of $10.00 per unit, at the option of the lender. The units would
be identical to the Private Units.
We
believe we will need to raise additional funds in order to meet the expenditures required for operating our business. If our estimate
of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than
the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our initial Business
Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated
to redeem a significant number of our public shares upon completion of our Business Combination, in which case we may issue additional
securities or incur debt in connection with such Business Combination.
16
Off-Balance Sheet FinancingArrangements
We
have no obligations, assets or liabilities that would be considered off-balance sheet arrangements as of March 31, 2022. We do not participate
in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest
entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into
any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities,
or purchased any non-financial assets.
Contractual Obligations
We
do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement
to pay the Sponsor a monthly fee of $10,000 for certain general and administrative services, including office space, utilities and administrative
services, provided to the Company. We began incurring these fees on December 15, 2021 and will continue to incur these fees monthly until
the earlier of the completion of a Business Combination and the Company’s liquidation.
The underwriters are entitled
to a deferred fee of two and one-half percent (2.5%) of the gross proceeds of the Initial Public Offering, or $2,875,000. The deferred
fee will be paid in cash upon the closing of a Business Combination from the amounts held in the Trust Account, subject to the terms
of the underwriting agreement.
Critical AccountingPolicies
The
preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in
the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities,
disclosure of contingent assets and liabilities at the date of the condensed financial statements, and income and expenses during the
periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Warrants
The
Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s
specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards
Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging
(“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet
the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under
ASC 815, including whether the warrants are indexed to the Company’s own ordinary shares and whether the warrant holders could
potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions
for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance
and as of each subsequent quarterly period end date while the warrants are outstanding.
For
issued or modified warrants that meet all of the criteria for equity classification, the warrants are required to be recorded as a component
of equity at the time of issuance. For issued or modified warrants that do not meet all the criteria for equity classification, the warrants
are required to be recorded as liabilities at their initial fair value on the date of issuance, and each balance sheet date thereafter.
Changes in the estimated fair value of the warrants are recognized as a non-cash gain or loss on the statements of operations.
Ordinary Shares Subjectto Possible Redemption
The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification
(“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Ordinary shares subject to mandatory redemption are
classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares
that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain
events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified
as stockholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside
of the Company’s control and subject to occurrence of uncertain future events. Accordingly, ordinary shares subject to possible
redemption are presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s
condensed balance sheets.
17
Net Income (Loss) PerOrdinary Share
We
apply the two-class method in calculating earnings per share. Ordinary shares subject to possible redemption, which are not currently
redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such
shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. Our net income (loss) is adjusted for the
portion of income that is attributable to ordinary shares subject to redemption, as these shares only participate in the earnings of
the Trust Account and not our income or losses.
Recent accounting standards
Management
does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect
on our interim condensed financial statements.
ITEM 3. QUANTITATIVEAND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As
of March 31, 2022, we were not subject to any market or interest rate risk. Following the consummation of our Initial Public Offering,
the net proceeds of our Initial Public Offering, including amounts in the Trust Account, have been invested in certain U.S. government
securities with a maturity of 180 days or less or in certain money market funds that invest solely in U.S. treasuries. Due to the short-term
nature of these investments, we believe there will be no associated material exposure to interest rate risk.
ITEM 4. CONTROLS ANDPROCEDURES
Disclosure
controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our
reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in
the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed
to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated
to our management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules 13a-15 and 15d-15 under the Exchange
Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation
of our disclosure controls and procedures as of March 31, 2022. Based upon their evaluation, our Chief Executive Officer and Chief Financial
Officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were
effective.
Changes in InternalControl Over Financial Reporting
During
the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting that has materially
affected, or is reasonably likely to materially affect, our internal control over financial reporting.
18
PART II
- OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
The Company is not party to any legal proceedings as of the filing date of this Form 10-Q.
ITEM 1A. RISK FACTORS.
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our annual report on the Form 10K for the fiscal year ended December 31, 2021 under Forward-Looking Statements and Item 1A – Risk Factors, filed with the SEC. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021.
ITEM 2. UNREGISTEREDSALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
Simultaneously with the closing of the Company’s IPO, the Company consummated the private placement (“Private Placement”) with its sponsor, A-Star Management Corp., a British Virgin Islands company (“Sponsor”) for the purchase of 330,000 Units (the “Private Units”) at a price of $10.00 per Private Unit, generating total proceeds of $3,300,000, pursuant to the Private Placement Unit Purchase Agreement dated December 13, 2021. Each Private Unit purchased by the Sponsor consists of one Shares, one right to receive one-seventh 1/7) of a Share upon the consummation of a business combination and one private placement warrant exercisable to purchase one-half (1/2) of one Share at a price of $10.00 per Share. The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, as the transactions did not involve a public offering.
Use of Proceeds
The registration statement for our initial public offering was declared effective by the Securities and Exchange Commission on December 13, 2021. We completed our initial public offering on December 15, 2021. In our initial public offering, we sold units at an offering price of $10.00 and consisting of one ordinary share, one right and one redeemable warrant. Each right entitles the holders thereof to receive one seventh (1/7) of one ordinary shares upon the consumption of the initial business combination. Each warrant entitles the holder thereof to purchase one-half of one ordinary share. We will not issue fractional shares in connection with the exercise of the warrants. In connection with our initial public offering, we sold 11,500,000 units, generating gross proceeds of $115,000,000.
Simultaneously with the closing of the IPO, pursuant to the Private Placement Units Purchase Agreement by and between the Company and our sponsor, A-Star Management Corporation, the Company completed the private sale of an aggregate of 330,000 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $3,300,000.
Transaction costs related to our IPO amounted to $5,669,696, consisting of $2,300,000 of underwriting fees, $2,875,000 of deferred underwriting fees and $494,696 of other offering costs. A total of $115,000,000, comprised of $112,700,000 of the proceeds from the IPO (which amount includes up to $2,875,000 of the underwriter’s deferred discount) and $2,300,000 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based trust account maintained at Wilmington Trust, National Association, acting as trustee. Except with respect to interest earned on the funds in the trust account that may be released to the Company to pay its taxes, the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly tendered in connection with a shareholder vote to amend the Company’s amended and restated memorandum and articles of association to (A) modify the substance or timing of its obligation to redeem 100% of the Company’s public shares if it does not complete its initial business combination within 9 months from the closing of the IPO (or up to 21 months from the closing of the IPO if we extend the period of time to consummate a business combination), or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity, and (iii) the redemption of the Company’s public shares if it is unable to complete its initial business combination within 9 months from the closing of the IPO (or up to 21 months from the closing of the IPO if we extend the period of time to consummate a business combination.
For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
ITEM 3. DEFAULTS UPONSENIOR SECURITIES.
None.
ITEM 4. MINE SAFETYDISCLOSURES.
Not
applicable.
ITEM 5. OTHER INFORMATION.
None.
19
ITEM 6. EXHIBITS.
The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.
20
SIGNATURES
Pursuant
to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
| ALPHA STAR ACQUISITION CORPORATION | ||
|---|---|---|
| Date:<br><br> May 13, 2022 | /s/<br>Zhe Zhang | |
| Name: | Zhe Zhang | |
| Title: | Chief Executive Officer<br><br> (Principle Executive Officer) | |
| Date:<br><br> May 13, 2022 | /s/<br>Guojian Chen | |
| Name: | Guojian Chen | |
| Title: | Chief Financial Officer<br><br> (Principle Financial Officer) |
21
Exhibit31.1
CERTIFICATIONSOF CHIEF EXECUTIVE OFFICERPURSUANT TO SECTION 302
I, Zhe Zhang, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Alpha Star Acquisition Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
| a. | Designed<br>such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure<br>that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those<br>entities, particularly during the period in which this report is being prepared; |
|---|---|
| b. | [Paragraph<br>intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942]; |
| --- | --- |
| c. | Evaluated<br>the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the<br>effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation;<br>and |
| --- | --- |
| d. | Disclosed<br>in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s<br>most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,<br>or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and |
| --- | --- |
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
| a. | All<br>significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably<br>likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and | |
|---|---|---|
| b. | Any<br>fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal<br>control over financial reporting. | |
| --- | --- | |
| Date:<br> May 13, 2022 | By: | /s/<br> Zhe Zhang |
| --- | --- | --- |
| Zhe Zhang | ||
| Chief<br> Executive Officer and Chairman | ||
| (Principal<br> Executive Officer) |
Exhibit31.2
CERTIFICATIONSOF CHIEF FINANCIAL OFFICERPURSUANT TO SECTION 302
I, Guojian Chen, certify that:
1. I have reviewed this Quarterly Report on Form 10-Q of Alpha Star Acquisition Corporation;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;
4. The Registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:
| a. | Designed<br>such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure<br>that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those<br>entities, particularly during the period in which this report is being prepared; |
|---|---|
| b. | [Paragraph intentionally omitted in accordance with SEC Release Nos. 34-47986 and 34-54942]; |
| --- | --- |
| c. | Evaluated<br>the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the<br>effectiveness of the disclosure controls and procedures as of the end of the period covered by this report based on such evaluation;<br>and |
| --- | --- |
| d. | Disclosed<br>in this report any change in the Registrant’s internal control over financial reporting that occurred during the Registrant’s<br>most recent fiscal quarter (the Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected,<br>or is reasonably likely to materially affect, the Registrant’s internal control over financial reporting; and |
| --- | --- |
5. The Registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):
| a. | All<br>significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably<br>likely to adversely affect the Registrant’s ability to record, process, summarize and report financial information; and | |
|---|---|---|
| b. | Any<br>fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal<br>control over financial reporting. | |
| --- | --- | |
| Date:<br> May 13, 2022 | By: | /s/<br> Guojian Chen |
| --- | --- | --- |
| Guojian<br> Chen<br><br> Chief Financial Officer | ||
| (Principal<br> Financial and Accounting Officer) |
Exhibit32.1
CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Alpha Star Acquisition Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
| Date:<br> May 13, 2022 | By: | /s/<br> Zhe Zhang |
|---|---|---|
| Zhe<br> Zhang | ||
| Chief<br> Executive Officer and Chairman | ||
| (Principal<br> Executive Officer) |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
Exhibit32.2
CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Alpha Star Acquisition Corporation (the “Company”) on Form 10-Q for the period ended March 31, 2022 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacities and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to her knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
| Date:<br> May 13, 2022 | By: | /s/<br> Guojian Chen |
|---|---|---|
| Guojian<br> Chen<br><br> Chief Financial Officer | ||
| (Principal<br> Financial and Accounting Officer) |
A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.